(Q30409734)

21 June 2017

title

Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard (English)

1 reference

World Health Organization

21 June 2017

0 references

0 references

1 reference

1 reference

8

Jacqueline M Katz

1 reference

21 June 2017

John M Wood

1

1 reference

21 June 2017

Diane Major

2

1 reference

21 June 2017

Alan Heath

3

1 reference

21 June 2017

Robert W Newman

4

1 reference

21 June 2017

Katja Höschler

5

1 reference

21 June 2017

Iain Stephenson

6

1 reference

21 June 2017

Tristan Clark

7

1 reference

21 June 2017

Maria C Zambon

9

1 reference

21 June 2017

language of work or name

English

0 references

publication date

17 November 2011

1 reference

21 June 2017

1 reference

21 June 2017

volume

30

1 reference

21 June 2017

issue

2

1 reference

21 June 2017

page(s)

210-217

1 reference

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.019

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.019

Determinants of immunity to influenza infection in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.019

Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.019

Comparison of influenza serological techniques by international collaborative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.019

Report of a collaborative study to calibrate the Second International Standard for parvovirus B19 antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.019

Effect of clinical and virological parameters on the level of neutralizing antibody against pandemic influenza A virus H1N1 2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.019

Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.019

Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December 2009.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.019

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2011.11.019

1 reference

21 June 2017

1 reference